LIVE
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India. Track Vijaya Diagnostic Centre Limited's live NSE:VIJAYA share price ₹1,363.80 (+1.44%), market cap ₹₹140B, P/E 81.1. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for VIJAYA — real-time NSE India stock intelligence.
Open
₹1,342.00
High
₹1,369.70
Low
₹1,334.60
Prev. Close
₹1,344.40
52W High
₹1,440.00
52W Low
₹848.00
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.
Key Takeaway
Vijaya Diagnostic Centre Limited is rated none with a P/E of 81.1x — understand the valuation context before sizing a position.
★ Recommended
Ask AI: Is Vijaya Diagnostic Centre Limited fairly valued right now?
Because a P/E of 81.1x needs to be compared against sector peers and growth expectations to be meaningful.
Continue Research
View events affecting Vijaya Diagnostic Centre Limited
Because the investment case must account for macro and company-specific developments — events reveal the 'why' behind price moves.
Trace sector ripple effects
Because Healthcare moves create upstream and downstream implications that affect the entire thesis.
Intelligence Path
Growth
Govt Exposure
Policy Dependence
Execution Quality
News Sensitivity
Debt Strength
219 Cr
Revenue
48 Cr
Net Profit
19.7%
ROE
0%
ROCE
16.81
EPS
| ₹ in Crore | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|
| Revenue | 459 | 548 | 681 | 814 | 785 |
| Net Profit | 85 | 119 | 144 | 173 | 164 |
| ROE (%) | — | — | — | 19.7% | 19.7% |
| EPS (₹) | — | — | — | 16.81 | 16.81 |
| Debt/Equity | — | — | — | 44.1 | 44.1 |